Oral fingolimod for chronic inflammatory demyelinating polyradiculoneuropathy (FORCIDP Trial): a double-blind, multicentre, randomised controlled trial

Richard Hughes, Marinos C Dalakas, Ingemar Merkies, Norman Latov, Jean-Marc Léger, Eduardo Nobile-Orazio, Gen Sobue, Angela Genge, David Cornblath, Martin Merschhemke, Carolyn Marie Ervin, Catherine Agoropoulou, Hans-Peter Hartung, Timothy Day, Judith Spies, Leslie Roberts, Philip Van Damme, Peter YK Van den Bergh, Alain Maertens de Noordhout, Annie Dionne, Sandrine Larue, Rami Massie, Michel Melanson, William Camu, Jérôme De Seze, Gwendal Le Masson, Jean Pouget, Jens Schmidt, Vasilios K Kimiskidis, Joab Chapman, Vivian E Drory, Raffaella Fazio, Francesca Gallia, Susumu Kusunoki, Masahiro Mori, Masahiro Iijima, Tomoko Okamoto, Masayuki Baba, Catharina G Faber, Ivo N van Schaik, Waldemar Fryze, Ewa Motta, Krzysztof Selmaj, Carlos Casasnovas, Antonio Guerrero Sola, Isabel Illa, James Holt, James AL Miller, Michael P Lunn, Thomas H Brannagan, Martin Brown, John Kelemen, Stanley Iyadurai, Kourosh Rezania, Khema R Sharma, Rup Tandan, Mark Gudesblatt, Victoria Lawson, Anthony A Amato

Open source

DOI
10.1016/s1474-4422(18)30202-3
Published
2018-08
Container
The Lancet Neurology
Publisher
Elsevier BV
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1016/s1474-4422-18-30202-3,
  title = {Oral fingolimod for chronic inflammatory demyelinating polyradiculoneuropathy (FORCIDP Trial): a double-blind, multicentre, randomised controlled trial},
  author = {Richard Hughes and Marinos C Dalakas and Ingemar Merkies and Norman Latov and Jean-Marc Léger and Eduardo Nobile-Orazio and Gen Sobue and Angela Genge and David Cornblath and Martin Merschhemke and Carolyn Marie Ervin and Catherine Agoropoulou and Hans-Peter Hartung and Timothy Day and Judith Spies and Leslie Roberts and Philip Van Damme and Peter YK Van den Bergh and Alain Maertens de Noordhout and Annie Dionne and Sandrine Larue and Rami Massie and Michel Melanson and William Camu and Jérôme De Seze and Gwendal Le Masson and Jean Pouget and Jens Schmidt and Vasilios K Kimiskidis and Joab Chapman and Vivian E Drory and Raffaella Fazio and Francesca Gallia and Susumu Kusunoki and Masahiro Mori and Masahiro Iijima and Tomoko Okamoto and Masayuki Baba and Catharina G Faber and Ivo N van Schaik and Waldemar Fryze and Ewa Motta and Krzysztof Selmaj and Carlos Casasnovas and Antonio Guerrero Sola and Isabel Illa and James Holt and James AL Miller and Michael P Lunn and Thomas H Brannagan and Martin Brown and John Kelemen and Stanley Iyadurai and Kourosh Rezania and Khema R Sharma and Rup Tandan and Mark Gudesblatt and Victoria Lawson and Anthony A Amato},
  year = {2018},
  journal = {The Lancet Neurology},
  doi = {10.1016/s1474-4422(18)30202-3},
  url = {https://doi.org/10.1016/s1474-4422(18)30202-3}
}

RIS

TY  - JOUR
TI  - Oral fingolimod for chronic inflammatory demyelinating polyradiculoneuropathy (FORCIDP Trial): a double-blind, multicentre, randomised controlled trial
AU  - Richard Hughes
AU  - Marinos C Dalakas
AU  - Ingemar Merkies
AU  - Norman Latov
AU  - Jean-Marc Léger
AU  - Eduardo Nobile-Orazio
AU  - Gen Sobue
AU  - Angela Genge
AU  - David Cornblath
AU  - Martin Merschhemke
AU  - Carolyn Marie Ervin
AU  - Catherine Agoropoulou
AU  - Hans-Peter Hartung
AU  - Timothy Day
AU  - Judith Spies
AU  - Leslie Roberts
AU  - Philip Van Damme
AU  - Peter YK Van den Bergh
AU  - Alain Maertens de Noordhout
AU  - Annie Dionne
AU  - Sandrine Larue
AU  - Rami Massie
AU  - Michel Melanson
AU  - William Camu
AU  - Jérôme De Seze
AU  - Gwendal Le Masson
AU  - Jean Pouget
AU  - Jens Schmidt
AU  - Vasilios K Kimiskidis
AU  - Joab Chapman
AU  - Vivian E Drory
AU  - Raffaella Fazio
AU  - Francesca Gallia
AU  - Susumu Kusunoki
AU  - Masahiro Mori
AU  - Masahiro Iijima
AU  - Tomoko Okamoto
AU  - Masayuki Baba
AU  - Catharina G Faber
AU  - Ivo N van Schaik
AU  - Waldemar Fryze
AU  - Ewa Motta
AU  - Krzysztof Selmaj
AU  - Carlos Casasnovas
AU  - Antonio Guerrero Sola
AU  - Isabel Illa
AU  - James Holt
AU  - James AL Miller
AU  - Michael P Lunn
AU  - Thomas H Brannagan
AU  - Martin Brown
AU  - John Kelemen
AU  - Stanley Iyadurai
AU  - Kourosh Rezania
AU  - Khema R Sharma
AU  - Rup Tandan
AU  - Mark Gudesblatt
AU  - Victoria Lawson
AU  - Anthony A Amato
PY  - 2018
JO  - The Lancet Neurology
DO  - 10.1016/s1474-4422(18)30202-3
UR  - https://doi.org/10.1016/s1474-4422(18)30202-3
ER  -

APA

Hughes, R., Dalakas, M. C., Merkies, I., Latov, N., Léger, J., Nobile-Orazio, E., Sobue, G., Genge, A., Cornblath, D., Merschhemke, M., Ervin, C. M., Agoropoulou, C., Hartung, H., Day, T., Spies, J., Roberts, L., Damme, P. V., Bergh, P. Y. V. D., Noordhout, A. M. D., Dionne, A., Larue, S., Massie, R., Melanson, M., Camu, W., Seze, J. D., Masson, G. L., Pouget, J., Schmidt, J., Kimiskidis, V. K., Chapman, J., Drory, V. E., Fazio, R., Gallia, F., Kusunoki, S., Mori, M., Iijima, M., Okamoto, T., Baba, M., Faber, C. G., Schaik, I. N. V., Fryze, W., Motta, E., Selmaj, K., Casasnovas, C., Sola, A. G., Illa, I., Holt, J., Miller, J. A., Lunn, M. P., Brannagan, T. H., Brown, M., Kelemen, J., Iyadurai, S., Rezania, K., Sharma, K. R., Tandan, R., Gudesblatt, M., Lawson, V., & Amato, A. A. (2018). Oral fingolimod for chronic inflammatory demyelinating polyradiculoneuropathy (FORCIDP Trial): a double-blind, multicentre, randomised controlled trial. The Lancet Neurology. https://doi.org/10.1016/s1474-4422(18)30202-3

Source records